LICAMINLIMAB
UNII D5ZJ707VIR

Substance Identification & Data

This profile provides standardized clinical and technical data for Licaminlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D5ZJ707VIR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1688648-13-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D5ZJ707VIR

CAS Registry Number

1688648-13-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LICAMINLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179100

National Cancer Institute reference terminology for clinical and research data.

INN ID

11526

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-109

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Licaminlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LICAMINLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN SCFV, ANTI-(HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR, TNFSF2, DIF, TNF-ALPHA)), HUMANIZED MONOCLONAL ANTIBODY SINGLE CHAIN; IG SCFV HUMANIZED SINGLE CHAIN (V-KAPPA-VH) (1-254) (V-KAPPA (HOMO SAPIENS IGKV1-5*03 (79.2%) -(IGHD) -IGKJ2*02 (77.8%)) CDR-IMGT (8.3.11) (28-35.53-55.92-102) (1-112)) -21-MER GLYCYL-TETRAKIS(TETRAGLYCYL-SERYL) LINKER (113-133) -(VH (HOMO SAPIENS IGHV3-66*01 (76%) -IGHJ6*01 (92.3%)) CDR-IMGT (8.8.14) (159-166.184-191.230-243) (134-254)), PRODUCED IN THE BACTERIA ESCHERICHIA COLI (E. COLI), NON-GLYCOSYLATED

IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR NECROSIS FACTOR .ALPHA.)(HUMAN-ORYCTOLAGUS CUNICULUS MONOCLONAL ESBA1622 SCFV FRAGMENT)

LICAMINLIMAB [INN]

LICAMINLIMAB [USAN]